Clinical & Experimental Metastasis

Papers
(The median citation count of Clinical & Experimental Metastasis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis96
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG70
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics53
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)47
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria37
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models36
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches35
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma29
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption21
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression20
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics20
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection19
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss17
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review17
Oncolytic intralesional therapy for metastatic melanoma17
Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials17
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions16
Cell blebbing novel therapeutic possibilities to counter metastasis16
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage 16
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells15
Axillary nodal staging in breast cancer: what have we learned?15
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis15
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression15
Therapy resistance and metastasis15
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations14
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer14
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer14
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer13
Fluid shear stress influences invasiveness of HeLa cells through the induction of autophagy13
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis13
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade13
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis13
Current preclinical models of brain metastasis12
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo12
Defining the landscape of metabolic dysregulations in cancer metastasis12
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker12
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells11
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection11
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model11
Etiology and treatment of cancer-related secondary lymphedema10
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations10
Histopathological growth patterns of neuroendocrine tumor liver metastases10
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis10
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis10
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study10
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results9
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK19
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy 9
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study9
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?9
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics9
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation9
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis8
Correction: Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival8
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy8
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases8
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis8
Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study8
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma8
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER28
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy7
TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer7
Empowering study of breast cancer data with application of artificial intelligence technology: promises, challenges, and use cases7
FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells7
Immune responses and immunotherapeutic approaches in the treatment against cancer7
Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors7
Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review7
Less contrast-enhanced areas within lymph nodes in the delayed phase of contrast-enhanced MRI: a suspicious finding for lymph node metastases7
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer7
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer7
Application of CTC discoveries for liquid biopsy: the RPL/RPS gene signature of melanoma CTCs is linked to brain metastasis onset6
Interrogating the roles of lymph node metastasis in systemic immune surveillance6
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology6
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance6
Correction to: Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis6
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)6
Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis6
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis6
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity5
Introduction: Novel Frontiers in Cancer Metastasis5
International cooperation to fight cancer’s late-stage presentation in low- and middle-income countries5
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?5
CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling5
Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells5
Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis5
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study5
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review5
Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment5
The role of epigenetic modifications in Colorectal Cancer Metastasis5
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis5
Immunotherapy of cancer in the era of checkpoint inhibitor4
Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer4
Membrane Lipid Replacement for reconstituting mitochondrial function and moderating cancer-related fatigue, pain and other symptoms while counteracting the adverse effects of cancer cytotoxic therapy4
miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF64
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review4
Factors associated with the distribution of brain metastases in lung cancer: a retrospective study4
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?4
Detecting and monitoring tumors in orthotopic colorectal liver metastatic animal models with high-resolution ultrasound4
Associations amongst genes, molecules, cells, and organs in breast cancer metastasis4
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer4
miRNAs in pancreatic cancer progression and metastasis4
Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study4
Review old bone, new tricks4
Downregulation of LINC00886 facilitates epithelial–mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma4
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer3
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis3
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer3
Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world3
UBTF mediates activation of L3MBTL2 to suppress NISCH expression through histone H2AK119 monoubiquitination modification in breast cancer3
Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models3
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion3
Clinical applications of circulating tumor cells in patients with solid tumors3
The gastrointestinal microbiota in colorectal cancer cell migration and invasion3
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer3
Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels3
Mapping the single cell spatial immune landscapes of the melanoma microenvironment3
Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review3
Surgical resection versus stereotactic radiosurgery for the treatment of brain metastases in the motor cortex; a meta-analysis and systematic review3
Establishment and Image based evaluation of a New Preclinical Rat Model of Osteoblastic Bone Metastases3
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)3
Cancer metastasis through the lymphatic versus blood vessels3
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy3
Brain metastases from hepatopancreatobiliary malignancies3
Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model3
Repurposing fluphenazine to suppress melanoma brain, lung and bone metastasis by inducing G0/G1 cell cycle arrest and apoptosis and disrupting autophagic flux3
Future perspectives: Novel Frontiers in Cancer Metastasis3
Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases3
Neoadjuvant therapy for resectable melanoma3
0.027611970901489